Medical societies and patient advocates together with EHA call for urgent action to make clinical trials less bureaucratic and more patient-centered
Over the last few years, clinical trials have become increasingly difficult and expensive to conduct, due in great measure to the disproportionate volume of bureaucratic demands involved.
Second consultation of EULAR Feedback on the EU Pharmaceuticals Strategy Roadmap
EULAR calls on the European Commission, the other European institutions and the Member States to improve access to affordable pharmaceuticals.
EULAR Press Releases
Read the latest:
- EULAR: Workplace exclusion of people with arthritis compounded by COVID-19
- The EULAR School of Rheumatology wins Awards for excellence in learning
EULAR Recommendations 2020
Read the latest:
- EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
EULAR Feedback on the EU Pharmaceuticals Strategy Roadmap
EULAR welcomes the initiative of the European Commission to modernise and update the existing regulatory framework for pharmaceutical products in the European Union.
EULAR RheumaMap: Unmet needs in 2020
The RheumaMap has been updated in 2019. Find out about the unmet needs in rheumatology in this latest edition.
The EULAR - COVID-19 Reporting Database for rheumatologists and other clinicians
To report cases of COVID-19 in patients with RMDs
02. June 2021
EULAR 2021 | PARIS
in Paris, FranceGo to Website
01. September 2021
Scandinavian Congress of Rheumatology
in Alesund, Norway.Visit Website
07. October 2021
Musculoskeletal Ultrasound in Rheumatology (Basic Course)
Rome, ItalyRead the programme
02. December 2021
Central European Congress of Rheumatology
in Bratislava, Slowakia.
Go to Website
03. April 2022
20th International Vasculitis and ANCA Workshop
Dublin, IrelandVisit Website
See the full calendar